- Report
- August 2026
- 182 Pages
Global
From €3137EUR$3,545USD£2,688GBP
€3485EUR$3,939USD£2,987GBP
- Report
- August 2026
- 177 Pages
Global
From €5176EUR$5,850USD£4,436GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- January 2026
- 185 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Clinical Trials
- May 2026
- 280 Pages
Global
From €2654EUR$3,000USD£2,275GBP
- Report
- February 2026
- 200 Pages
Global
From €7070EUR$7,990USD£6,058GBP
- Report
- May 2026
- 100 Pages
Global
From €2388EUR$2,699USD£2,046GBP
- Report
- April 2026
- 137 Pages
Global
From €2654EUR$2,999USD£2,274GBP
€3538EUR$3,999USD£3,032GBP
- Report
- October 2025
- 160 Pages
Global
From €2796EUR$3,160USD£2,396GBP
€3495EUR$3,950USD£2,995GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- February 2026
- 250 Pages
Global
From €3973EUR$4,490USD£3,404GBP
- Report
- November 2025
- 185 Pages
Global
From €3982EUR$4,500USD£3,412GBP
- Report
- January 2026
- 240 Pages
Global
From €3097EUR$3,500USD£2,654GBP
- Report
- May 2026
- 200 Pages
Global
From €2468EUR$2,789USD£2,115GBP
- Report
- April 2026
- 160 Pages
Global
From €2938EUR$3,320USD£2,517GBP
€3672EUR$4,150USD£3,147GBP
- Report
- October 2025
- 160 Pages
Global
From €2796EUR$3,160USD£2,396GBP
€3495EUR$3,950USD£2,995GBP
- Report
- December 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP
- Report
- October 2025
- 150 Pages
Global
From €4291EUR$4,850USD£3,677GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more